Deutsche Bank raised the firm’s price target on GSK (GSK) to 1,675 GBp from 1,600 GBp and keeps a Hold rating on the shares.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- Trump Trade: White House releases details on ‘Great Healthcare Plan’
- Drugmakers concerned about legal risk with FDA review program, Reuters reports
- White House releases details on Trump ‘Great Healthcare Plan’
- GSK price target raised to 1,600 GBp from 1,500 GBp at Morgan Stanley
- Trump Trade: Trump administration moves to end pharma trade probe